Related Experiment Video
Updated: Jul 2, 2026

Measurement of Tissue Non-Heme Iron Content using a Bathophenanthroline-Based Colorimetric Assay
Published on: January 31, 2022
Could iron deposits in hepatocytes serve as a prognostic marker of HFE gene mutations?
Katarzyna Sikorska1, Piotr Stalke, Kazimierz Jaskiewicz
1Department of Infectious Diseases, Medical University of Gdansk, Gdansk, Poland. ksikorska@amg.gda.pl
Insights
Iron deposits in liver tissue correlate with HFE gene mutations in patients with chronic liver disease (CLD). This finding aids in diagnosing hereditary hemochromatosis (HH) by linking liver iron levels to specific genetic markers.
Area of Science:
- Hepatology
- Medical Genetics
- Clinical Biochemistry
Background:
- Hereditary hemochromatosis (HH) diagnosis relies on tissue iron and genetic testing.
- Chronic liver diseases (CLD) can present with iron deposition.
- The HFE gene is crucial in HH pathogenesis.
Purpose of the Study:
- To investigate the correlation between hepatic iron deposits and HFE gene mutations in CLD patients.
- To assess the diagnostic utility of liver iron assessment in relation to HFE genotypes.
Main Methods:
- Screening of HFE gene mutations (C282Y, H63D, S65C) using PCR-RFLP in 182 CLD patients.
- Assessment of liver function, viral hepatitis serology, iron, ferritin, and semiquantitative liver iron.
- Division of patients into groups based on the presence (Group B) or absence (Group A) of liver iron deposits.
Main Results:
- Group B (with iron deposits) showed significantly higher biochemical markers of iron storage and ALT activity.
- HFE gene mutations, including C282Y homozygotes and C282Y/H63D heterozygotes, were more frequent in Group B.
- Chronic hepatitis C was the most common cause of CLD in the study population.
Conclusions:
- Liver iron deposits identified in routine liver specimens correlate with the presence of various HFE gene mutations.
- This correlation can enhance the diagnostic approach to hereditary hemochromatosis in patients with chronic liver disease.
Background/Aims:
The diagnosis of hereditary hemochromatosis (HH) is based on qualitative measurement of tissue iron concentration and genetic tests. The aim of this study was to evaluate the correlation between the presence of iron deposits in the liver and the HFE gene mutations in patients with chronic liver diseases (CLD).
Methodology:
The 182 patients, age range 18-71 years, were hospitalized in Gdansk because of CLD. The C282Y, H63D and S65C HFE mutations were screened by PCR-RFLP analysis. Liver function tests, serological examinations for viral hepatitis, serum iron and ferritin concentration and semiquantitative assessment of liver iron were done in all subjects. Patients were divided into Group A without iron deposits in the liver, and Group B with deposits. The most frequent etiology of CLD was chronic hepatitis C.
Results:
Biochemical parameters indicating iron storage and ALT activity were significantly higher in Group B. Either typical for diagnosis HH homozygotes C282Y/C282Y and combined heterozygotes C282Y/H63D or carriers of other HFE gene mutations were found significantly more frequently in Group B.
Conclusions:
The finding of iron deposits in routinely obtained liver specimen correlates with occurrence of the different HFE gene mutations.
Related Concept Videos
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Hepatitis
Liver Regeneration
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are large...
The Early Endosome: Endocytosis of Transferrin

